138 related articles for article (PubMed ID: 30780032)
1. Chronic myeloid leukemia: Two mysteries.
Radivoyevitch T; Jorgensen TN; Lindner DJ; Maciejewski JP; Miyazaki Y; Gale RP
Leuk Res; 2019 Apr; 79():3-5. PubMed ID: 30780032
[No Abstract] [Full Text] [Related]
2. Parameter perturbations in a post-treatment chronic myeloid leukemia model capture the essence of pre-diagnosis A-bomb survivor mysteries.
Radivoyevitch T
Radiat Environ Biophys; 2021 Mar; 60(1):41-47. PubMed ID: 33125593
[TBL] [Abstract][Full Text] [Related]
3. Medical diagnostic X-ray irradiation and risk of leukemia in urban adult population of Poland. II. Bone marrow dose distributions.
Gajewski AK; Rózycki Z; Słowikowska MG; Krzyzanowski M; Majle T
Rocz Panstw Zakl Hig; 1988; 39(5):337-43. PubMed ID: 3247568
[No Abstract] [Full Text] [Related]
4. The risk of chronic myeloid leukemia: can the dose-response curve be U-shaped?
Radivoyevitch T; Kozubek S; Sachs RK
Radiat Res; 2002 Jan; 157(1):106-9. PubMed ID: 11754648
[TBL] [Abstract][Full Text] [Related]
5. Biologically based risk estimation for radiation-induced CML. Inferences from BCR and ABL geometric distributions.
Radivoyevitch T; Kozubek S; Sachs RK
Radiat Environ Biophys; 2001 Mar; 40(1):1-9. PubMed ID: 11357705
[TBL] [Abstract][Full Text] [Related]
6. Why is there so much therapy-related AML and MDS and so little therapy-related CML?
Gale RP; Hlatky L; Sachs RK; Radivoyevitch T
Leuk Res; 2014 Oct; 38(10):1162-4. PubMed ID: 25175829
[No Abstract] [Full Text] [Related]
7. [Chronic myeloid leukemia].
Matsuo T; Tomonaga M
Nihon Rinsho; 2001 Nov; 59 Suppl 7():529-36. PubMed ID: 11808163
[No Abstract] [Full Text] [Related]
8. Heyssel R, Brill AB, Woodbury LA, et al. Leukemia in Hiroshima atomic bomb survivors. Blood. 1960;15(3):313-331.
Blood; 2016 May; 127(18):2165. PubMed ID: 27151734
[No Abstract] [Full Text] [Related]
9. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.
Ishimaru T; Otake M; Ischimaru M
Radiat Res; 1979 Feb; 77(2):377-94. PubMed ID: 286375
[No Abstract] [Full Text] [Related]
10. [Clinical epidemiology].
Ohyashiki K
Nihon Rinsho; 2001 Dec; 59(12):2416-20. PubMed ID: 11766349
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in the incidence of chronic myeloid leukemia.
Radivoyevitch T; Jankovic GM; Tiu RV; Saunthararajah Y; Jackson RC; Hlatky LR; Gale RP; Sachs RK
Radiat Environ Biophys; 2014 Mar; 53(1):55-63. PubMed ID: 24337217
[TBL] [Abstract][Full Text] [Related]
12. Chronic myelogenous leukemia following repeated radiation therapy for histiocytosis X.
Chap L; Nimer SD
Leuk Lymphoma; 1994 Jan; 12(3-4):315-6. PubMed ID: 8167563
[TBL] [Abstract][Full Text] [Related]
13. 9;22 translocation and bcr rearrangements in chronic myelocytic leukemia patients among atomic bomb survivors.
Tanaka K; Takechi M; Hong J; Shigeta C; Oguma N; Kamada N; Takimoto Y; Kuramoto A; Dohy H; Kyo T
J Radiat Res; 1989 Dec; 30(4):352-8. PubMed ID: 2614751
[TBL] [Abstract][Full Text] [Related]
14. What do atomic bomb survivors teach us about therapy-free remission in people with chronic myeloid leukaemia?
Radivoyevitch T; Gale RP; Kalaycio ME
Leukemia; 2024 Jan; 38(1):207-209. PubMed ID: 37949937
[No Abstract] [Full Text] [Related]
15. Therapy-related chronic myeloid leukemia: an epidemiological, clinical and pathogenetic appraisal.
Aguiar RC
Leuk Lymphoma; 1998 Mar; 29(1-2):17-26. PubMed ID: 9638972
[TBL] [Abstract][Full Text] [Related]
16. Late effect of atomic bomb radiation on myeloid disorders: leukemia and myelodysplastic syndromes.
Tsushima H; Iwanaga M; Miyazaki Y
Int J Hematol; 2012 Mar; 95(3):232-8. PubMed ID: 22370711
[TBL] [Abstract][Full Text] [Related]
17. Incidence of leukemia in atomic bomb survivors belonging to a fixed cohort in Hiroshima and Nagasaki, 1950--71. Radiation dose, years after exposure, age at exposure, and type of leukemia.
Ichimaru M; Ishimaru T; Belsky JL
J Radiat Res; 1978 Sep; 19(3):262-82. PubMed ID: 739446
[No Abstract] [Full Text] [Related]
18. Leukemia following radiotherapy for uterine bleeding.
Inskip PD; Monson RR; Wagoner JK; Stovall M; Davis FG; Kleinerman RA; Boice JD
Radiat Res; 1990 May; 122(2):107-19. PubMed ID: 2336456
[TBL] [Abstract][Full Text] [Related]
19. Biologically-based risk estimation for radiation-induced chronic myeloid leukemia.
Radivoyevitch T; Hoel DG
Radiat Environ Biophys; 2000 Sep; 39(3):153-9. PubMed ID: 11095145
[TBL] [Abstract][Full Text] [Related]
20. Age of onset and type of leukaemia.
Butturini A; Gale RP
Lancet; 1989 Sep; 2(8666):789-91. PubMed ID: 2571022
[No Abstract] [Full Text] [Related]
[Next] [New Search]
